Egelund EF[Author] - Search Results

Year	Number of Results
2010	1
2011	2
2012	2
2013	2
2014	7
2015	4
2016	4
2017	1
2018	2
2019	3
2020	3
2021	2
2022	2
2023	2
2024	1

1

Egelund EF, Bucciarelli AL. Egelund EF, et al. JAMA. 2022 Aug 9;328(6):509-510. doi: 10.1001/jama.2021.24029. JAMA. 2022. PMID: 35862060 No abstract available.

2

Medications and monitoring in nontuberculous mycobacteria infections.

Egelund EF, Fennelly KP, Peloquin CA. Egelund EF, et al. Clin Chest Med. 2015 Mar;36(1):55-66. doi: 10.1016/j.ccm.2014.11.001. Epub 2014 Dec 18. Clin Chest Med. 2015. PMID: 25676519 Review.

3

Optimizing the clinical pharmacology of tuberculosis medications.

Egelund EF, Alsultan A, Peloquin CA. Egelund EF, et al. Clin Pharmacol Ther. 2015 Oct;98(4):387-93. doi: 10.1002/cpt.180. Epub 2015 Jul 22. Clin Pharmacol Ther. 2015. PMID: 26138226 Review.

4

MenQuadfi (MenACWY-TT): A New Vaccine for Meningococcal Serogroups ACWY.

Huston J, Galicia K, Egelund EF. Huston J, et al. Among authors: egelund ef. Ann Pharmacother. 2022 Jun;56(6):727-735. doi: 10.1177/10600280211039873. Epub 2021 Aug 29. Ann Pharmacother. 2022. PMID: 34459258 Review.

5

Brincidofovir: A Novel Agent for the Treatment of Smallpox.

Huston J, Curtis S, Egelund EF. Huston J, et al. Among authors: egelund ef. Ann Pharmacother. 2023 Oct;57(10):1198-1206. doi: 10.1177/10600280231151751. Epub 2023 Jan 23. Ann Pharmacother. 2023. PMID: 36688308 Review.

6

Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?

Brooks KM, Sherman EM, Egelund EF, Brotherton A, Durham S, Badowski ME, Cluck DB. Brooks KM, et al. Among authors: egelund ef. Pharmacotherapy. 2019 May;39(5):576-598. doi: 10.1002/phar.2246. Epub 2019 Apr 1. Pharmacotherapy. 2019. PMID: 30860610 Review.

7

Tenofovir Alafenamide for the Treatment of Chronic Hepatitis B Monoinfection.

Childs-Kean LM, Egelund EF, Jourjy J. Childs-Kean LM, et al. Among authors: egelund ef. Pharmacotherapy. 2018 Oct;38(10):1051-1057. doi: 10.1002/phar.2174. Epub 2018 Sep 9. Pharmacotherapy. 2018. PMID: 30120841 Review.

8

A HAART-Breaking Review of Alternative Antiretroviral Administration: Practical Considerations with Crushing and Enteral Tube Scenarios.

Huesgen E, DeSear KE, Egelund EF, Smith R, Max B, Janelle J. Huesgen E, et al. Among authors: egelund ef. Pharmacotherapy. 2016 Nov;36(11):1145-1165. doi: 10.1002/phar.1835. Epub 2016 Oct 20. Pharmacotherapy. 2016. PMID: 27636237 Review.

9

CYP2C19 polymorphisms and therapeutic drug monitoring of voriconazole: are we ready for clinical implementation of pharmacogenomics?

Owusu Obeng A, Egelund EF, Alsultan A, Peloquin CA, Johnson JA. Owusu Obeng A, et al. Among authors: egelund ef. Pharmacotherapy. 2014 Jul;34(7):703-18. doi: 10.1002/phar.1400. Epub 2014 Feb 7. Pharmacotherapy. 2014. PMID: 24510446 Free PMC article. Review.

10

Editorial commentary: pharmacokinetic variability and tuberculosis treatment outcomes, including acquired drug resistance.

Egelund EF, Peloquin CA. Egelund EF, et al. Clin Infect Dis. 2012 Jul;55(2):178-9. doi: 10.1093/cid/cis366. Epub 2012 Mar 30. Clin Infect Dis. 2012. PMID: 22467672 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

31 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year